In this issue:
Transdermal oestradiol for androgen suppression in prostate cancer
Clinically meaningful positive surgical margins in radical prostatectomy
PSMA-PET/CT-based lymph node atlas for prostate cancer patients
[177Lu]Lu-PSMA-617 for metastatic castration-resistant prostate cancer
ADT + radiotherapy in intermediate-risk prostate cancer
Cost-effectiveness of PSMA-PET/CT in prostate cancer
Predictive value of 3-T mpMRI and 68Ga-PSMA PET/CT
Mediterranean diet and progression in localised prostate cancer
Ultra-hypofractionated vs conventionally fractionated radiotherapy
Please login below to download this issue (PDF)